Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

Principles of neural science

(1982) · Trends in Neurosciences · doi:10.1016/0166-2236(82)90076-5 · Cited by 9,148 · see citing works

Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069 · see citing works

Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria

Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047 · see citing works

The Global Deterioration Scale for assessment of primary degenerative dementia

Reisberg, ‌., Ferris, S. H., de Leon, M. J., & Crook, T. H. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.9.1136 · Cited by 4,982 · see citing works

Vascular dementia: Diagnostic criteria for research studies: Report of the NINDS‐AIREN International Workshop*

Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921 · see citing works

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop

McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · see citing works

J Neuropsychiatry Clin Neurosci

Yudofsky, S. C., & Hales, R. E. (1992) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.4.4.359 · Cited by 3,818 · see citing works

Cornell scale for depression in dementia

Alexopoulos, G. S., Abrams, R. C., Young, R. C., & Shamoian, C. A. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90038-8 · Cited by 2,678 · see citing works

DSM-IV: Diagnostic and Statistical Manual of Mental Disorders

Bell, C. C. (1994) · JAMA · doi:10.1001/jama.1994.03520100096046 · Cited by 2,608 · see citing works

Principles of Neural Science

Calabrese, V. P. (1992) · JAMA · doi:10.1001/jama.1992.03490230111048 · Cited by 2,517 · see citing works

A Description of Agitation in a Nursing Home

Cohen-mansfield, J., Marx, M. S., & Rosenthal, A. S. (1989) · Journal of Gerontology · doi:10.1093/geronj/44.3.m77 · Cited by 1,349 · see citing works

Untitled work

(1987) · PubMed · Cited by 1,147 · see citing works

Synthesis of a Fluorescent Derivatizing Reagent, 6-Aminoquinolyl-N-Hydroxysuccinimidyl Carbamate, and Its Application for the Analysis of Hydrolysate Amino Acids via High-Performance Liquid Chromatography

Cohen, S. A., & Michaud, D. P. (1993) · Analytical Biochemistry · doi:10.1006/abio.1993.1270 · Cited by 983 · see citing works

Behavioral and Psychological Signs and Symptoms of Dementia: A Consensus Statement on Current Knowledge and Implications for Research and Treatment

Finkel, S. I., Miller, S., Silva, J. C. E., Cohen, G. D., & Sartorius, N. (1997) · International Psychogeriatrics · doi:10.1017/s1041610297003943 · Cited by 651 · see citing works

The Clinical Efficacy of Citalopram in Treatment of Emotional Disturbances in Dementia Disorders a Nordic Multicentre Study

Nyth, A. L., & Gottfries, C. G. (1990) · The British Journal of Psychiatry · doi:10.1192/bjp.157.6.894 · Cited by 379 · see citing works

Dopamine Transporter Loss Visualized With FP-CIT SPECT in the Differential Diagnosis of Dementia With Lewy Bodies

O'Brien, J. T., Colloby, S. J., Fenwick, J., Williams, E. D., Firbank, M., Burn, D. J., Aarsland, D., & McKeith, I. G. (2004) · Archives of Neurology · doi:10.1001/archneur.61.6.919 · Cited by 334 · see citing works

Principles of Neural Science, 3rd ed

Bloom, F. E. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.11.1739 · Cited by 326 · see citing works

The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer's disease patients

Schnaider Beeri, M., Werner, P., Davidson, M., & Noy, S. (2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.490 · Cited by 284 · see citing works

Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia

Engelborghs, S., de Vreese, K., de Casteele, T. V., Vanderstichele, H., Everbroeck, B. V., Cras, P. P., Martin, J., Vanmechelen, E., & Deyn, P. P. D. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.02.016 · Cited by 256 · see citing works

Cholinergic–serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease

Garcia-Alloza, M., Gil-Bea, F. J., Diez-Ariza, M., Chen, C. P. L.-H., Francis, P. T., Lasheras, B., & Ramirez, M. J. (2005) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2004.06.007 · Cited by 244 · see citing works

Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms

Walters, R. J., Hadley, S. H., Morris, K. D. W., & Αmin, J. (2000) · Nature Neuroscience · doi:10.1038/81800 · Cited by 243 · see citing works

Taurine prevents the neurotoxicity of β‐amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders

Louzada, P., Lima, A. C. P., Mendonça-Silva, D., Noël, F., de Mello, F. G., & Ferreira, S. (2004) · The FASEB Journal · doi:10.1096/fj.03-0739com · Cited by 239 · see citing works

Noradrenergic changes, aggressive behavior, and cognition in patients with dementia

Matthews, K. L., Chen, C., Esiri, M. M., Keene, J., Minger, S. L., & Francis, P. T. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01235-5 · Cited by 211 · see citing works

Interacting neurotransmitter systems. A non-experimental approach to the 5hiaa-hva correlation in human CSF

→Agren, H., Mefford, I. N., Rudorfer, M. V., Linnoila, M., & Potter, W. Z. (1986) · Journal of Psychiatric Research · doi:10.1016/0022-3956(86)90002-6 · Cited by 201 · see citing works

Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease

Lanari, A., Amenta, F., Silvestrelli, G., Tomassoni, D., & Parnetti, L. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.09.016 · Cited by 180 · see citing works

Introduction to behavioural and psychological symptoms of dementia (BPSD)

Finkel, S. I. (2000) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(200004)15:1+ · Cited by 174 · see citing works

Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons.

Kelland, M. D., Freeman, A. S., & Chiodo, L. A. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13049-8 · Cited by 171 · see citing works

Role of Serotonin in the Behavioral and Psychological Symptoms of Dementia

Lanctôt, K. L., Herrmann, N., & Mazzotta, P. (2001) · Journal of Neuropsychiatry · doi:10.1176/jnp.13.1.5 · Cited by 153 · see citing works

Determination of serotonin, noradrenaline, dopamine and their metabolites in rat brain extracts and microdialysis samples by column liquid chromatography with fluorescence detection following derivatization with benzylamine and 1,2-diphenylethylenediamine

Yoshitake, T., Kehr, J., Yoshitake, S., Fujino, K., Nohta, H., & Yamaguchi, M. (2004) · Journal of Chromatography B · doi:10.1016/j.jchromb.2004.03.069 · Cited by 120 · see citing works

The Role of Norepinephrine in the Behavioral and Psychological Symptoms of Dementia

Herrmann, N., Lanctôt, K. L., & Khan, L. R. (2004) · Journal of Neuropsychiatry · doi:10.1176/jnp.16.3.261 · Cited by 118 · see citing works

Neuropsychiatric symptoms of dementia: cross-sectional analysis from a prospective, longitudinal Belgian study

Engelborghs, S., Maertens, K., Nagels, G., Vloeberghs, E., Mariën, P., Symons, A., Ketels, V., Estercam, S., Somers, N., & Deyn, P. P. D. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1395 · Cited by 111 · see citing works

Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies

Goldman, J. G., Goetz, C. G., Brandabur, M., Sanfilippo, M., & Stebbins, G. T. (2008) · Movement Disorders · doi:10.1002/mds.22322 · Cited by 109 · see citing works

The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia

Engelborghs, S., Vloeberghs, E., Bastard, N. L., Buggenhout, M. V., Mariën, P., Somers, N., Nagels, G., Pickut, B. A., & Deyn, P. P. D. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2007.10.018 · Cited by 95 · see citing works

Amino Acids and Biogenic Amines in Cerebrospinal Fluid of Patients with Parkinson's Disease

Engelborghs, S., Marescau, B., & Deyn, P. P. D. (2003) · Neurochemical Research · doi:10.1023/a:1024255208563 · Cited by 88 · see citing works

The impact of taurine- and beta-alanine-supplemented diets on behavioral and neurochemical parameters in mice: antidepressant versus anxiolytic-like effects

Murakami, T., & Furuse, M. (2010) · Amino Acids · doi:10.1007/s00726-009-0458-x · Cited by 87 · see citing works

The Middelheim Frontality Score: a behavioural assessment scale that discriminates frontotemporal dementia from Alzheimer's disease

Deyn, P. P. D., Engelborghs, S., Saerens, J., Goeman, J., Mariën, P., Maertens, K., Nagels, G., Martin, J., & Pickut, B. A. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1249 · Cited by 85 · see citing works

Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: A 123 I‐FP‐CIT SPECT study

Roselli, F., Pisciotta, N., Perneczky, R., Pennelli, M., Aniello, M. S., Caro, M. F. D., Ferrannini, E., Tartaglione, B., Defazio, G., Rubini, G., et al. (2009) · Movement Disorders · doi:10.1002/mds.22702 · Cited by 85 · see citing works

Abnormal amino acid metabolism in patients with early stage Alzheimer dementia

Fekkes, D., van der Cammen, T. J. M., van Loon, C. P. M., Verschoor, C. J., van Harskamp, F., de Koning, I., Schudel, W. J., & Pepplinkhuizen, L. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050058 · Cited by 84 · see citing works

Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease

Garcı́a-Alloza, M., Tsang, S. W. Y., Gil-Bea, F. J., Francis, P. T., Lai, M. K. P., Marcos, B., Chen, C., & Ramírez, M. J. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.06.003 · Cited by 77 · see citing works

Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease

Sweet, R. A., Devlin, B., Pollock, B. G., Sukonick, D. L., Kastango, K. B., Bacanu, S., Chowdari, K. V., DeKosky, S. T., & Ferrell, R. E. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001709 · Cited by 75 · see citing works

CSF excitatory amino acids and severity of illness in Alzheimer's disease

Csernansky, J. G., Bardgett, M. E., Sheline, Y. I., Morris, J. C., & Olney, J. W. (1996) · Neurology · doi:10.1212/wnl.46.6.1715 · Cited by 72 · see citing works

A preliminary study of free amino acids in the postmorten temporal cortex from Alzheimer-type dementia patients

Arai, H., Kobayashi, K., Ichimiya, Y., Kosaka, K., & Iizuka, R. (1984) · Neurobiology of Aging · doi:10.1016/0197-4580(84)90009-5 · Cited by 70 · see citing works

Taurine, an inducer for tau polymerization and a weak inhibitor for amyloid-β-peptide aggregation

Santa‐María, I., Hernández, F., Moreno, F. J., & Ávila, J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.09.068 · Cited by 65 · see citing works

Long-Term L-DOPA Treatment Causes Indiscriminate Increase in Dopamine Levels at the Cost of Serotonin Synthesis in Discrete Brain Regions of Rats

Borah, A., & Mohanakumar, K. P. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9213-6 · Cited by 64 · see citing works

The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis

Weamer, E. A., Emanuel, J. E., Varón, D., Miyahara, S., Wilkosz, P. A., López, O. L., DeKosky, S. T., & Sweet, R. A. (2008) · International Psychogeriatrics · doi:10.1017/s1041610208007734 · Cited by 60 · see citing works

Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug–naive schizophrenic patients

Schmitt, G., Frodl, T., Dresel, S., la Fougére, C., Bottlender, R., Koutsouleris, N., Hahn, K., Möller, H., & Meisenzahl, E. (2006) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-005-0618-2 · Cited by 53 · see citing works

Altered Glutamate Neurotransmission and Behaviour in Dementia: Evidence from Studies of Memantine

Francis, P. T. (2009) · Current Molecular Pharmacology · doi:10.2174/1874467210902010077 · Cited by 51 · see citing works

Association between cerebral glutamate and human behaviour: The sensation seeking personality trait

Gallinat, J., Kunz, D., Lang, U. E., Neu, P., Kassim, N., Kienast, T., Seifert, F. C., Schubert, F., & Bajbouj, M. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.10.004 · Cited by 47 · see citing works

Cerebral Metabolic Changes in a Depression-like Rat Model of Chronic Forced Swimming Studied by Ex vivo High Resolution 1H Magnetic Resonance Spectroscopy

Li, C., Wang, Y., Gao, H., Pan, W., Xiang, Y., Huang, M., & Lei, H. C. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9739-0 · Cited by 46 · see citing works

Continuous covariability of dopamine and serotonin metabolites in human cerebrospinal fluid

Geracioti, T. D., Keck, P. E., Ekhator, N. N., West, S. A., Baker, D. G., Hill, K. K., Bruce, A. B., & Wortman, M. D. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)90372-3 · Cited by 45 · see citing works

Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia

Suh, G., Greenspan, A. J., & Choi, S. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1693 · Cited by 34 · see citing works

Taurine trials in animal models offer no support for anxiolytic, antidepressant or stimulant effects.

Whirley, B. K., & Einat, H. (2008) · PubMed · Cited by 31 · see citing works

Cerebrospinal fluid taurine in alzheimer's disease

Alom, J., Mahy, J. N., Brandi, N., & TOLOSA, E. S. (1991) · Annals of Neurology · doi:10.1002/ana.410300518 · Cited by 18 · see citing works

Acute l-DOPA Effect on Hydroxyl Radical- and DOPAC-Levels in Striatal Microdialysates of Parkinsonian Rats

Nowak, P. G., Kostrzewa, R. A., Skaba, D. R., & Kostrzewa, R. M. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9105-2 · Cited by 15 · see citing works

Neuropsychiatric symptoms in Alzheimer's disease: what might be associated brain circuits?

Rosenberg, P. B., Nowrangi, M. A., & Lyketsos, C. G. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.05.005 · Cited by 302 · see citing works

Neurotransmitter deficits from frontotemporal lobar degeneration

Murley, A. G., & Rowe, J. B. (2017) · Brain · doi:10.1093/brain/awx327 · Cited by 199 · see citing works

Age‐ and disease‐specific changes of the kynurenine pathway in Parkinson’s and Alzheimer’s disease

Sorgdrager, F. J. H., Vermeiren, Y., van Faassen, M. H. J. R., van der Ley, C., Nollen, E. A. A., Kema, I. P., & Deyn, P. P. D. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14843 · Cited by 154 · see citing works

Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management

O'Brien, J. T., Taylor, J., Ballard, C. G., Barker, R. A., Bradley, C., Burns, A. S., Collerton, D., Dave, S., Dudley, R. E. J., Francis, P. T., et al. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-322702 · Cited by 136 · see citing works

Roles of taurine in cognitive function of physiology, pathologies and toxication

Chen, C., Xia, S., He, J., Lu, G., Xie, Z., & Han, H. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116584 · Cited by 132 · see citing works

GABA and glutamate deficits from frontotemporal lobar degeneration are associated with disinhibition

Murley, A. G., Rouse, M. A., Jones, P. S., Ye, R., Hezemans, F. H., O’Callaghan, C., Frangou, P., Kourtzi, Z., Rua, C., Carpenter, T. A., et al. (2020) · Brain · doi:10.1093/brain/awaa305 · Cited by 101 · see citing works

Taurine Supplementation as a Neuroprotective Strategy upon Brain Dysfunction in Metabolic Syndrome and Diabetes

Rafiee, Z., García-Serrano, A. M., & Duarte, J. M. N. (2022) · Nutrients · doi:10.3390/nu14061292 · Cited by 100 · see citing works

Toward a glutamate hypothesis of frontotemporal dementia

Benussi, A., Alberici, A., Buratti, E., Ghidoni, R., Gardoni, F., Di Luca, M., Padovani, A., & Borroni, B. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00304 · Cited by 90 · see citing works

Psychosis in Frontotemporal Dementia

Shinagawa, S., Nakajima, S., Plitman, E., Graff‐Guerrero, A., Mimura, M., Nakayama, K., & Miller, B. L. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140312 · Cited by 79 · see citing works

Brain Region-Specific Monoaminergic Correlates of Neuropsychiatric Symptoms in Alzheimer's Disease

Vermeiren, Y., Dam, D. V., Aerts, T., Engelborghs, S., & Deyn, P. P. D. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140309 · Cited by 65 · see citing works

Neuropharmacology of the Neuropsychiatric Symptoms of Dementia and Role of Pain: Essential Oil of Bergamot as a Novel Therapeutic Approach

Scuteri, D., Rombolà, L., Morrone, L. A., Bagetta, G., Sakurada, S., Sakurada, T., Tonin, P., & Corasaniti, M. T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133327 · Cited by 60 · see citing works

The Behavioral and Psychological Symptoms of Dementia in Down Syndrome (BPSD-DS) Scale: Comprehensive Assessment of Psychopathology in Down Syndrome

Dekker, A. D., Sacco, S., Carfì, A., Benejam, B., Vermeiren, Y., Beugelsdijk, G., Schippers, M., Hassefras, L., Eleveld, J., Grefelman, S., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170920 · Cited by 55 · see citing works

Homovanillic acid in CSF of mild stage Parkinson's disease patients correlates with motor impairment

Stefani, A., Pierantozzi, M., Olivola, E., Galati, S., Cerroni, R., D’Angelo, V., Hainsworth, A. H., Saviozzi, V., Fedele, E., & Liguori, C. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.01.007 · Cited by 53 · see citing works

The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer’s disease

Vermeiren, Y., Dam, D. V., Aerts, T., Engelborghs, S., Martin, J., & Deyn, P. P. D. (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0090-1 · Cited by 52 · see citing works

Neurotransmitter measures in the cerebrospinal fluid of patients with Alzheimer's disease: a review.

Štrac, D. Š., Mück‐Šeler, D., & Pivac, N. (2015) · PubMed · Cited by 51 · see citing works

Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer’s Disease

Vermeiren, Y., Janssens, J., Aerts, T., Martin, J., Sieben, A., Dam, D. V., & Deyn, P. P. D. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160320 · Cited by 50 · see citing works

Recent Trends in the Quantification of Biogenic Amines in Biofluids as Biomarkers of Various Disorders: A Review

Plenis, A., Olędzka, I., Kowalski, P., Miękus, N., & Bączek, T. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050640 · Cited by 49 · see citing works

High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer’s Disease

Yu, J., Kong, L. D., Zhang, A., Han, Y., Liu, Z., Sun, H. J., Liu, L., & Wang, X. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00206 · Cited by 48 · see citing works

Effects of bioactive molecules on the concentration of biogenic amines in foods and biological systems

Tsafack, P. B., & Tsopmo, A. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e10456 · Cited by 45 · see citing works

Alzheimer's disease biomarkers as predictors of trajectories of depression and apathy in cognitively normal individuals, mild cognitive impairment , and Alzheimer's disease dementia

Banning, L. C. P., Ramakers, I. H. G. B., Rosenberg, P. B., Lyketsos, C. G., Leoutsakos, J., & Initiative, A. D. N. (2020) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5418 · Cited by 45 · see citing works

Plasma BDNF levels are correlated with aggressiveness in patients with amnestic mild cognitive impairment or Alzheimer disease

Nagata, T., Kobayashi, N., Shinagawa, S., Yamada, H., Kondo, K., & Nakayama, K. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1121-y · Cited by 45 · see citing works

Serum MHPG Strongly Predicts Conversion to Alzheimer's Disease in Behaviorally Characterized Subjects with Down Syndrome

Dekker, A. D., Coppus, A. M. W., Vermeiren, Y., Aerts, T., van Duijn, C. M., Kremer, B. P. H., Naudé, P., Dam, D. V., & Deyn, P. P. D. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140783 · Cited by 42 · see citing works

EEG-based neurophysiological indicators of hallucinations in Alzheimer's disease: Comparison with dementia with Lewy bodies

Dauwan, M., Linszen, M. M. J., Lemstra, A. W., Scheltens, P., Stam, C. J., & Sommer, I. E. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.013 · Cited by 37 · see citing works

Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis

Janssens, J., Vermeiren, Y., Fransén, E., Aerts, T., Dam, D. V., Engelborghs, S., & Deyn, P. P. D. (2018) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.01.002 · Cited by 36 · see citing works

Apolipoprotein E and affective symptoms in mild cognitive impairment and Alzheimer’s disease dementia: A systematic review and meta-analysis

Banning, L. C. P., Ramakers, I. H. G. B., Deckers, K., Verhey, F. R. J., & Aalten, P. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.11.020 · Cited by 34 · see citing works

Several dementia subtypes and mild cognitive impairment share brain reduction of neurotransmitter precursor amino acids, impaired energy metabolism, and lipid hyperoxidation

Aquilani, R., Ramusino, M. C., Maestri, R., Iadarola, P., Boselli, M., Perini, G., Boschi, F., Dossena, M., Bellini, A., Buonocore, D., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1237469 · Cited by 33 · see citing works

Behavioral And Psychological Symptoms In Dementia

Cloak, N. L., & Khalili, Y. A. (2020) · StatPearls · Cited by 29 · see citing works

An overview of the pathophysiology of agitation in Alzheimer’s dementia with a focus on neurotransmitters and circuits

Cummings, J. L., Brubaker, M., Selzler, K. J., Gonzalez, S. T., Patel, M., & Stahl, S. M. (2024) · CNS Spectrums · doi:10.1017/s1092852924000427 · Cited by 27 · see citing works

Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease

van der Zee, S., Vermeiren, Y., Fransén, E., Dam, D. V., Aerts, T., Gerritsen, M. J. J., Spikman, J. M., van Laar, T., & Deyn, P. P. D. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-171228 · Cited by 21 · see citing works

Sampling issues of cerebrospinal fluid and plasma monoamines: Investigation of the circadian rhythm and rostrocaudal concentration gradient

Janssens, J., Atmosoerodjo, S. D., Vermeiren, Y., Absalom, A. R., den Daas, I., & Deyn, P. P. D. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.04.015 · Cited by 21 · see citing works

Evaluation of a mobile team dedicated to behavioural disorders as recommended by the Alzheimer Cooperative Valuation in Europe joint action: observational cohort study

Krolak‐Salmon, P., Roubaud, C., Finne‐Soveri, H., Riolacci‐Dhoyen, N., Richard, G., Rouch, I., Leperre‐Desplanques, A., & Dauphinot, V. (2016) · European Journal of Neurology · doi:10.1111/ene.12975 · Cited by 15 · see citing works

Aggression, Agitation, Hyperactivity, and Irritability

Frederiksen, K., & Waldemar, G. (2017) · Neuropsychiatric symptoms of neurological disease · doi:10.1007/978-3-319-39138-0_9 · Cited by 13 · see citing works

Delirium and Behavioral Symptoms in Persons With Dementia at Hospital Admission

Boltz, M. P., Kuzmik, A., Resnick, B. M., BeLue, R., Jao, Y., Paudel, A., Behrens, L. L., LESLIE, D. L., Sinvani, L., & Galvin, J. E. (2023) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000552 · Cited by 10 · see citing works

Exploitation of Autophagy Inducers in the Management of Dementia: A Systematic Review

Corasaniti, M. T., Bagetta, G., Nicotera, P., Maione, S., Tonin, P., Guida, F., & Scuteri, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021264 · Cited by 9 · see citing works

Synthesis of versatile neuromodulatory molecules by a gut microbial glutamate decarboxylase

Dadi, P., Pauling, C. W., Shrivastava, A., & Shah, D. D. (2025) · iScience · doi:10.1016/j.isci.2025.112289 · Cited by 9 · see citing works

Exploring peripheral fluid biomarkers for early detection of Alzheimer's disease in Down syndrome: A literature review

Jacob, C., Tollenaere, M., Kachar, H., Potier, M., Deyn, P. P. D., & Dam, D. V. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e41445 · Cited by 5 · see citing works

Dysregulated Neurotransmitters and CB1 Receptor Dysfunction and Their Roles in Agitation Associated with Alzheimer’s Disease

Rao, J. S., Tangarife, M. A., Rodríguez‐Soacha, D. A., Arbelaez, M. J., Venegas, M. M., Delgado‐Murillo, L., Shahnawaz, S. S., Grimaldi, C., Gutiérrez, E., & Mukunda, R. (2025) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad2020015 · Cited by 4 · see citing works

Pharmacoutilization data-driven artificial intelligence–assisted diagnosis algorithm to improve the pharmacological treatment of pain and agitation in patients suffering from severe dementia

Scuteri, D., Adornetto, C., Greco, G., Nicotera, P., Bagetta, G., & Corasaniti, M. T. (2025) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2025.102563 · Cited by 3 · see citing works

La personalidad premórbida como factor de riesgo en la aparición de síntomas psicológicos y conductuales de la demencia: revisión sistemática

Bastida, J. D., Clemente, L. J., Font, S. J., & Cardona, E. A. (2018) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2018.08.006 · Cited by 3 · see citing works

Association between Low Vitamin D Status, Serotonin, and Clinico-Biobehavioral Parameters in Alzheimer’s Disease

Richter, A.-L., Bruin, M. D.-D., Balvers, M. G. J., de Groot, C. P. G. M., Deyn, P. P. D., Engelborghs, S., Witkamp, R. F., & Vermeiren, Y. (2023) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000534492 · Cited by 2 · see citing works

BIOmarkers in NEuropsychiatric SYmptoms (BIONESY): A multicenter nation survey and a systematic review

Perini, G., Ramusino, M. C., Vergani, M., Gatti, A., Imbimbo, C., Leone, S., Ballante, E., Allegri, N., D’Antonio, F., Zuffi, M., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251344631 · Cited by 2 · see citing works

Assessment of mexican arnica (Heterotheca inuloides Cass) and rosemary (Rosmarinus officinalis) extracts on dopamine and selected biomarkers of oxidative stress in stomach and brain of Salmonella typhimurium infected rats

Olguín, H., Guzmàn, D., Herrera, M., Brizuela, N. O., Mejía, G. B., García, E., Peraza, A. V., Ruíz, N. L., & Angel, D. D. (2017) · Pharmacognosy Magazine · doi:10.4103/0973-1296.204553 · Cited by 2 · see citing works

Role of Taurine and its Analogs Against Various Disorders and its Beneficial Effects: A Review Article

Ara, Z., Rastogi, D., Khan, A. A., & Waliullah, S. (2022) · Acta Scientific Medical Sciences · doi:10.31080/asms.2022.06.1367 · Cited by 2 · see citing works

Neuropsychiatric symptoms in Alzheimer’s disease

Banning (2019) · doi:10.26481/dis.20191220lb · Cited by 2 · see citing works

The behavioral and psychological symptoms of dementia in Down syndrome (BPSD-DS) scale: comprehensive assessment of psychopathology in Down syndrome

Dekker, A. D. (2018) · doi:10.26226/morressier.5b681760b56e9b005965c651 · Cited by 2 · see citing works

The Difference in Cognitive Profiles Between Patients With Alzheimer Dementia With and Without Psychosis

Carmel, J., Clerc, D., Couture, V., Reid, I., Filali, A., & Villalpando, J. M. (2024) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000644 · Cited by 1 · see citing works

Impact of Manganese on Neuronal Function: An Exploratory Multi-Omics Study on Ferroalloy Workers in Brescia, Italy

Azmoun, S., Lewis, F. C., Shoieb, D., Jin, Y., Colicino, E., Mhatre‐Winters, I., Gu, H., Krishnamurthy, H. K., Richardson, J. R., Placidi, D., et al. (2025) · Brain Sciences · doi:10.3390/brainsci15080829 · Cited by 1 · see citing works

Psychiatric Disorders in Dementia

Vermeiren, Y., Dam, D. V., & Deyn, P. P. D. (2014) · Springer eBooks · doi:10.1007/978-3-642-40384-2_11 · Cited by 1 · see citing works

Behavioural and Psychological Symptoms of Dementia in Hospital Settings

Hayer, R. K., & Tadros, G. (2024) · Cambridge University Press eBooks · doi:10.1017/9781108292252.011 · Cited by 1 · see citing works

Depression in Alzheimer's disease : biomarkers and treatment

Enache, D. (2015) · Figshare · Cited by 1 · see citing works

ANALYSIS OF NEUROTRANSMITTERS, NEUROSTEROIDS AND THEIR METABOLITES IN BIOLOGICAL SAMPLES

Suominen, T. (2015) · Työväentutkimus Vuosikirja

Psychiatric Disorders in Dementia

Vermeiren, Y., Dam, D. V., de Vries, M., & Deyn, P. P. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-57231-0_9

Las orexinas como biomarcadores para demencia tipo Alzheimer y relación con síntomas neuropsiquiátricos

Lozano-Tovar, S., Monroy‐Jaramillo, N., & Rodríguez‐Agudelo, Y. (2022) · Revista chilena de neuro-psiquiatría · doi:10.4067/s0717-92272022000300313

Ultrahigh-Field Magnetic Resonance Spectroscopy Findings Do Not Support Previous Brain Metabolite Findings in Major Depressive Disorder

Tamman, A. J. F., & Abdallah, C. G. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.12.022

Impact of Manganese on Neuronal Function: An Exploratory MultiOmic Study on Ferroalloy Workers in Brescia, ItalyPreprint

Azmoun, S., Lewis, F., Shoieb, D., Jin, Y., Colicino, E., Mhatre‐Winters, I., Gu, H., Krishnamurthy, H. K., Richardson, J. R., Placidi, D., et al. (2025) · medRxiv · doi:10.1101/2025.05.02.25326824

Cerebrospinal fluid catecholamines levels in Alzheimer’s disease, frontotemporal dementia, and normal controls

Moreira, I. P., Serrão, P., Sequeira, L., Sá, M. J., Guimarães, J., & Vieira‐Coelho, M. A. (2025) · Neurodegenerative Disease Management · doi:10.1080/17582024.2025.2554527

P4‐177: Correlates of cerebrospinal fluid neurotransmitter alterations with behavioral disturbances in dementia

Vermeiren, Y., Bastard, N. L., Hemelrijck, A. V., Drinkenburg, W. H. I. M., Deyn, P. P. D., & Engelborghs, S. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.2200

The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia

Engelborghs, S., Vloeberghs, E., Bastard, N. L., Buggenhout, M. V., Mariën, P., Somers, N., Nagels, G., Pickut, B. A., & Deyn, P. P. D. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2007.10.018 · Cited by 95 · see citing works

P3‐392: The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia

Engelborghs, S., Bastard, N. L., Vloeberghs, E., Buggenhout, M. V., Nagels, G., Pickut, B. A., & Deyn, P. P. D. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.1962 · Cited by 1 · see citing works

Behavioral correlates of cerebrospinal fluid concentrations of aminoacids and monoamine metabolites according to APOE-ɛ4 carrier status in dementia with Lewy bodies compared with Alzheimer’s dementia and cognitively healthy people (P4.190)

de Oliveira, F. F., Miraldo, M. C., de Castro-Neto, E. F., Machado, F. C., de Almeida, S. S., Matas, S. L. D. A., Bertolucci, P. H. F., & Naffah‐Mazzacoratti, M. D. G. (2018) · Neurology · doi:10.1212/wnl.90.15_supplement.p4.190

Comparative study of neurotransmitter levels in cerebrospinal fluid of patients with dementia with Lewy bodies, Alzheimer's disease dementia and control subjects

Miraldo, M. C. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)